Paul Reider

Insider Reports History

Location
C/O Coherus Biosciences, Inc., 333 Twin Dolphin Drive, Suite 600, Redwood City, CA
Signature
/s/ Bryan McMichael, as Attorney-in-Fact for Paul Reider
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Reider:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Coherus BioSciences, Inc. Chief Commercial Officer Common Stock 82.1K $114K $1.39 Jan 20, 2025 Direct
Coherus BioSciences, Inc. Chief Commercial Officer Stock Option (Right to Buy) 160K Jan 3, 2025 Direct

Insider Reports Filed by Paul Reider

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CHRS Coherus BioSciences, Inc. Jan 20, 2025 1 -$6.75K 4 Jan 22, 2025 Chief Commercial Officer
CHRS Coherus BioSciences, Inc. Jan 3, 2025 2 -$3.78K 4 Jan 7, 2025 Chief Commercial Officer
CHRS Coherus BioSciences, Inc. Dec 13, 2024 1 -$3.34K 4 Dec 17, 2024 Chief Commercial Officer
CHRS Coherus BioSciences, Inc. Jul 22, 2024 1 $0 4 Jul 24, 2024 Chief Commercial Officer
CHRS Coherus BioSciences, Inc. Jan 20, 2024 1 -$11.8K 4 Jan 23, 2024 Chief Commercial Officer
CHRS Coherus BioSciences, Inc. Jan 4, 2024 1 -$6.64K 4 Jan 8, 2024 Chief Commercial Officer
CHRS Coherus BioSciences, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 Chief Commercial Officer
CHRS Coherus BioSciences, Inc. Dec 13, 2023 1 -$4.86K 4 Dec 15, 2023 Chief Commercial Officer
CHRS Coherus BioSciences, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Chief Commercial Officer
CHRS Coherus BioSciences, Inc. Apr 1, 2023 1 -$16.8K 4 Apr 4, 2023 Chief Commercial Officer
CHRS Coherus BioSciences, Inc. Mar 20, 2023 0 $0 3 Mar 28, 2023 Chief Commercial Officer